Immuneering Corporation (IMRX), a clinical-stage oncology company, Thursday said it has signed a clinical supply agreement with ...

Immuneering (IMRX) announced a clinical supply agreement with Regeneron Pharmaceuticals (REGN) for its anti-PD-1 therapy, Libtayo. The supply ...

This was the stock's second consecutive day of gains.

The Prince William County School Board revised the adopted 2025-2026 school year calendar at its Jan. 22 meeting in a ...

Thursday, July 3rd, 2025 (prior to Independence Day) Friday, November 28th, 2025 (Black Friday) Wednesday, December 24th, 2025 (Christmas Eve) Note: If a holiday falls on a Saturday, the stock ...

State — See the Calendar of Legal Holidays for State Employees. RF — Employees required to work on a holiday will receive holiday leave credit. Time off should be scheduled when convenient for the ...

Your biospecimen will be sent to the Regeneron Genetics Center for genetic sequencing, then stored for future analysis. With something as sacred as your genetic material in its hands, Truveta and ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Investing.com -- UBS has downgraded Regeneron Pharmaceuticals Inc (NASDAQ:REGN) to "Neutral" from "Buy" given uncertainty around its key Eylea franchise. Brokerage slashed price target to $738 ...

Regeneron stock has trended bearishly since August, but growth in LIBTAYO and DUPIXENT offers a promising outlook, prompting a BUY rating. EYLEA HD's success mitigates biosimilar competition ...

On Wednesday, Bernstein analysts maintained their Outperform rating and $1,070.00 price target for Regeneron (NASDAQ:REGN) Pharmaceuticals (NASDAQ: REGN). Following a sell-side Q&A session with ...